, Tracking Stock Market Picks
Enter Symbol:
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

up 589.27 %

Acadia Pharmaceuticals Inc. (ACAD) rated Buy with price target $38 by Needham

Posted on: Thursday,  Mar 12, 2015  8:25 AM ET by Needham

Needham rated Buy Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) on 03/12/2015. Previously Needham rated Buy Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) on 11/27/2012.,
when the stock price was $5.50. Since then, Acadia Pharmaceuticals Inc. has gained 589.27% as of 01/25/2016's recent price of $37.91.
If you would have followed the previous Needham's recommendation on ACAD, you would have gained 589.27% of your investment in 1154 days.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2015 8:25 AM Buy
34.08 38.00
as of 8/27/2015
1 Week down  -3.14 %
1 Month down  -11.67 %
3 Months down  -2.91 %
1 YTD up  51.70 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/22/2014 8:25 AM Buy
32.75 40.00
8/7/2013 8:25 AM Buy
20.11 26.00
4/11/2013 10:25 AM Buy
11.73 16.00
11/27/2012 12:25 PM Buy
5.50 9.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy